BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35470679)

  • 1. Ongoing Exercise Intolerance Following COVID-19: A Magnetic Resonance-Augmented Cardiopulmonary Exercise Test Study.
    Brown JT; Saigal A; Karia N; Patel RK; Razvi Y; Constantinou N; Steeden JA; Mandal S; Kotecha T; Fontana M; Goldring J; Muthurangu V; Knight DS
    J Am Heart Assoc; 2022 May; 11(9):e024207. PubMed ID: 35470679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance-Augmented Cardiopulmonary Exercise Testing: Comprehensively Assessing Exercise Intolerance in Children With Cardiovascular Disease.
    Barber NJ; Ako EO; Kowalik GT; Cheang MH; Pandya B; Steeden JA; Moledina S; Muthurangu V
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary exercise study.
    Brown JT; Kotecha T; Steeden JA; Fontana M; Denton CP; Coghlan JG; Knight DS; Muthurangu V
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):118. PubMed ID: 34706740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of medium-term recovery status after COVID-19 illness on cardiopulmonary exercise capacity in a physically active adult population.
    Ladlow P; O'Sullivan O; Bennett AN; Barker-Davies R; Houston A; Chamley R; May S; Mills D; Dewson D; Rogers-Smith K; Ward C; Taylor J; Mulae J; Naylor J; Nicol ED; Holdsworth DA
    J Appl Physiol (1985); 2022 Jun; 132(6):1525-1535. PubMed ID: 35608204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing.
    Singh I; Joseph P; Heerdt PM; Cullinan M; Lutchmansingh DD; Gulati M; Possick JD; Systrom DM; Waxman AB
    Chest; 2022 Jan; 161(1):54-63. PubMed ID: 34389297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction.
    Santos M; Opotowsky AR; Shah AM; Tracy J; Waxman AB; Systrom DM
    Circ Heart Fail; 2015 Mar; 8(2):278-85. PubMed ID: 25550438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
    Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.
    Shimiaie J; Sherez J; Aviram G; Megidish R; Viskin S; Halkin A; Ingbir M; Nesher N; Biner S; Keren G; Topilsky Y
    JACC Heart Fail; 2015 Oct; 3(10):803-14. PubMed ID: 26449998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of left ventricular preload by cardiac magnetic resonance imaging predicts exercise capacity in adult operated tetralogy of Fallot: a retrospective study.
    Yap J; Tan JL; Le TT; Gao F; Zhong L; Liew R; Tan SY; Tan RS
    BMC Cardiovasc Disord; 2014 Sep; 14():122. PubMed ID: 25245139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men.
    Stratton JR; Levy WC; Cerqueira MD; Schwartz RS; Abrass IB
    Circulation; 1994 Apr; 89(4):1648-55. PubMed ID: 8149532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes.
    Nesti L; Pugliese NR; Sciuto P; De Biase N; Mazzola M; Fabiani I; Trico D; Masi S; Natali A
    Cardiovasc Diabetol; 2021 Jun; 20(1):124. PubMed ID: 34158062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Atrial Fibrillation on Exercise Capacity and Mortality in Heart Failure With Preserved Ejection Fraction: Insights From Cardiopulmonary Stress Testing.
    Elshazly MB; Senn T; Wu Y; Lindsay B; Saliba W; Wazni O; Cho L
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.
    Haykowsky MJ; Brubaker PH; John JM; Stewart KP; Morgan TM; Kitzman DW
    J Am Coll Cardiol; 2011 Jul; 58(3):265-74. PubMed ID: 21737017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass.
    Haykowsky MJ; Brubaker PH; Morgan TM; Kritchevsky S; Eggebeen J; Kitzman DW
    J Gerontol A Biol Sci Med Sci; 2013 Aug; 68(8):968-75. PubMed ID: 23525477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure.
    Kraemer MD; Kubo SH; Rector TS; Brunsvold N; Bank AJ
    J Am Coll Cardiol; 1993 Mar; 21(3):641-8. PubMed ID: 8436745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic and metabolic phenotyping of hypertensive patients with and without heart failure by combining cardiopulmonary and echocardiographic stress test.
    Pugliese NR; Mazzola M; Fabiani I; Gargani L; De Biase N; Pedrinelli R; Natali A; Dini FL
    Eur J Heart Fail; 2020 Mar; 22(3):458-468. PubMed ID: 31950651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive measurement of cardiac output and ventricular ejection fractions in chronic cardiac failure: relationship to impaired exercise tolerance.
    Steele IC; Moore A; Nugent AM; Riley MS; Campbell NP; Nicholls DP
    Clin Sci (Lond); 1997 Sep; 93(3):195-203. PubMed ID: 9337633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19.
    Ingul CB; Edvardsen A; Follestad T; Trebinjac D; Ankerstjerne OAW; Brønstad E; Rasch-Halvorsen Ø; Aarli B; Dalen H; Nes BM; Lerum TV; Einvik G; Stavem K; Skjørten I
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36137587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction.
    Haykowsky MJ; Nicklas BJ; Brubaker PH; Hundley WG; Brinkley TE; Upadhya B; Becton JT; Nelson MD; Chen H; Kitzman DW
    JACC Heart Fail; 2018 Aug; 6(8):640-649. PubMed ID: 30007558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of stress echocardiography and cardiopulmonary exercise testing to assess exercise intolerance in patients treated for acute myocardial infarction.
    Smarz K; Jaxa-Chamiec T; Zaborska B; Tysarowski M; Budaj A
    PLoS One; 2021; 16(8):e0255682. PubMed ID: 34351993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.